Latest News for: dsmb

Edit

Medera Receives DSMB Clearance to Initiate Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial for ...

Nasdaq Globe Newswire 20 Mar 2025
(“Medera”), a clinical-stage biopharmaceutical company focused on cardiovascular diseases with high unmet need by ...
Edit

MaaT Pharma Announces Positive Outcomes from Final DSMB Meeting for Pivotal Phase 3 Clinical Trial ...

Business Wire 19 Mar 2025
LYON, France--(BUSINESS WIRE)---- $MAAT #Cancer--MaaT Pharma Announces Positive Outcomes from Final DSMB Meeting for Pivotal Phase 3 Clinical Trial Evaluating MaaT013 in aGvHD ... .
Edit

MaaT Pharma Announces Positive Outcomes from Final DSMB Meeting for Pivotal Phase 3 Clinical Trial Evaluating MaaT013 in Acute Graft versus Host Disease (Maat Pharma SA)

Public Technologies 18 Mar 2025
"This DSMB's positive review is ... The DSMB confirmed that"giventhe remarkable efficacy results, the study results show an acceptable safety profile and a favorable benefit /risk ratio".
Edit

aTyr Pharma Announces Fourth Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in

Hastings Tribune 06 Mar 2025
(Nasdaq.
  • 1

Article Search

tools
×
×
×
×